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Abstract
Background: To evaluate the ocular pulse amplitude (OPA), the posterior pole asymmetry analysis (PPAA), the
peripapillary retinal nerve fiber layer (RNFL) thickness, the ganglion cell layer (GCL) thickness, macular thickness and
visual field testing in migraine patients without aura.
Methods: In this prospective, cross-sectional and comparative study 38 migraine patients and 44 age and sex
matched controls were included. OPA was measured by dynamic contour tonometry (DCT), PPAA, RNFL, GCL and
macular thickness were measured by Heidelberg Spectral Domain Optical Coherence Tomography (SD-OCT) and
standard perimetry was performed using the Humphrey automated field analyzer.
Results: The difference in OPA was not statistically significant between the two groups (p≥ 0.05). In the PPAA
there was no significant difference between two hemispheres in each eye (p ≥ 0.05). The RNFL thickness was
significantly reduced in the temporal and nasal superior sectors in the migraine group (p ≤ 0.05). The GCL and
macular thickness measurements were thinner in migraine patients but the difference between groups was not
statistically significant (p≥ 0.05). There was no correlation between RNFL, GCL, macular thickness measurements
and OPA values. There was no significant difference in the mean deviation (MD) and pattern standard deviation
(PSD) between the two groups (p≥ 0.05).
Conclusions: Migraine patients without aura have normal OPA values, no significant asymmetry of the posterior
pole and decreased peripapillary RNFL thickness in the temporal and nasal superior sectors compared with controls.
These findings suggest that there is sectorial RNFL thinning in migraine patients without aura and pulsative
choroidal blood flow may not be affected during the chronic course of disease.
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Background
Migraine is a form of headache that has been regarded
as a neurovascular disorder. The theories about its
mechanism do not provide satisfactory clarification and
the underlying pathophysiology still remains unclear. Re-
cent studies declared that neural events trigger vascular
dilatation, which aggravates the pain and results in further
nerve activation [1]. Migraine has several ocular manifes-
tations including visual disturbances during attacks [2],
visual field defects [3], reduction in retinal nerve fiber
layer (RNFL) thickness [4, 5], and normal tension glau-
coma [6]. Central retinal artery occlusion and ischemic
optic neuropathy were also reported previously, which
may indicate possible ocular vascular involvement as well
as central vascular system in migraine [7–9]. Vasospastic
events and ocular involvement were reported mostly in
migraine patients with aura [1].
Ocular pulse amplitude (OPA), which is described as
the difference between systolic and diastolic intraocular
pressure (IOP), is accepted as an indirect indicator of
choroidal perfusion [10]. It is measured by dynamic con-
tour tonometry, which is a contact tonometry providing
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intraocular pressure and OPA simultaneously and was
suggested as a diagnostic tool for diseases in which chor-
oidal perfusion changes might occur [10, 11].
The posterior pole asymmetry analysis (PPAA) is a
new method determining the hemisphere asymmetry of
the macula by comparing the thickness of the two hemi-
spheres on a map, which are divided into equal cells. It
is reported that PPAA could show early glaucomatous
damage before it could be documented by the optic disc
analysis [12]. Therefore, there is a current trend towards
investigating the change in PPAA in various ocular dis-
orders in which retinal ganglion cell or axonal damage
may occur.
The majority of migraine patients (85 %) have migraine
without aura [1]. Recently intracerebral vascular alter-
ations were reported in patients without aura which may
support that vascular dysregulation is an integral mechan-
ism of the migraine pathophysiology [13]. Therefore we
conducted this study to evaluate the ocular involvement
in migraine patients without aura, using OPA, PPAA,
peripapillary RNFL thickness, GCL thickness, macular
thickness and visual field test.
Methods
This prospective observational cross sectional study was
approved by the Ethical Committee of Pamukkale Univer-
sity and adhered to the tenets of the Declaration of
Helsinki. The study was conducted in the Department of
Ophthalmology and the Department of Neurology in our
university. All participants provided informed written
consent to participate in the study. The diagnostic
criteria for migraine without aura was based on the
international Classification of Headache Disorder
(ICHD-II) [14];
At least five of the following criteria need to be met:
 Treated or untreated headache attacks lasting 4 to
72 h.
Headache has at least two of the following
characteristics:
 Moderate or severe pain intensity.
 Pulsating quality.
 Unilateral location.
 Aggravation by physical activity or causing
avoidance of routine physical activity (eg, walking).
During a headache at least one of the following:
 Photophobia and phonophobia.
 Nausea and/or vomiting.
 Symptoms not associated with another disorder.
Study population
The participants were 38 migraine patients without aura
and 44 age and sex matched controls.
The exclusion criteria for both groups were;
 Age ≥ 45 (to exclude age related changing)
 Best corrected visual acuity (BCVA) with Snellen
chart < 1.0 (in decimals, any level of visual
impairment was excluded)
 Having spherical or cylindrical refractive error ≥ 2D
 Having any ocular disease that could affect the
RNFL thickness (glaucoma etc.)
 Previous ocular inflammation or surgery
 Any systemic or neurologic disorder
 Chronic drug use including migraine prophylactic
agents which could influence ocular blood flow and
RNFL thickness.
Examination techniques
All patients underwent detailed ophthalmic examination
including visual acuity, intraocular pressure with non
contact tonometry, ocular motility, anterior and posterior
segment evaluations. OCT measurements were performed
first, as DCT may cause transient corneal opacifications.
Visual field testing was performed on a separate day.
OPA was measured by dynamic contour tonometry
(DCT, Ziemer Ophthalmic Systems, Port, Switzerland)
after applying a topical anaesthetic eye drop. The DCT
is attached to a slit lamp, like classic applanation tonom-
eters, giving a medium value of 100 IOP measurements
per second and determines OPA, by providing dynamic
IOP measurements. The mean value of two reliable
measurements (Q1, Q2, Q3, as recommended by the
manufacturer) was used.
Without pupillary dilatation, the PPAA, peripapillary
RNFL thickness, GCL thickness and macular thickness
were analysed with the Heidelberg Spectral Domain Optical
Coherence Tomography (SD-OCT, Heidelberg Engineering,
Dossenheim, Germany). The images that individual retinal
layers could be identified were used. Asymmetry analysis of
the posterior pole was evaluated with a map which com-
pares the superior to inferior hemispheres (hemisphere
asymmetry) for each eye. See Fig. 1 for asymmetry analysis
of the posterior pole. One hemisphere includes 32 cells and
each cell has an equivalent in the opposite hemisphere. The
difference in retinal thickness between the two equivalent
cells are indicated with colors changing from white to
black. A black cell means that the difference in retinal
thickness is ≥30 μm. For cell to cell comparison between
two hemispheres, two or more consecutive black cells were
taken into consideration and recorded as asymmetry posi-
tivity. The peripapillary RNFL thickness was evaluated in
six sectors including temporal inferior, temporal, temporal
superior, nasal superior, nasal, nasal inferior. GCL thickness
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was measured on a central macular map which was
automatically divided into ETDRS macular fields with
a diameter of 1 mm (central sector),3 mm (internal
sectors) and 6 mm (external sectors) in horizontal
and vertical planes. The mean GCL thickness of cen-
tral macular field with a diameter of 3 mm was esti-
mated as the mean GCL thickness in each patient.
See Fig. 2 for topographic measurement of GCL
thickness.
Standard perimetry was performed using the central
30-2 threshold algorithm program on a Humphrey
automated field analyser (HFA, CarlZeiss Inc, Dublin,
California). The criteria for visual field reliability included
<20 % fixation loss and < 20 % false positive and negative
ratios. The test was repeated in patients with low reliabil-
ity. The mean deviation (MD) and pattern standard devi-
ation (PSD) values were recorded.
Randomly one eye of each participant was selected for
the comparison of the parameters between the migraine
and the control group.
Statistical analysis
Statistical analysis was performed by SPSS statistical
software 17.0 (SPSS Inc., Chicago, IL). Independent sam-
ples t test, Pearson’s correlation, and chi-square test
were used for statistical analysis. Descriptive statistics
were stated as means ± SD. A value of p ≤ 0.05 has been
accepted as significant.
Results
The mean age was 30.17 ± 11.15 years in the migraine
group, and 28.75 ± 7.06 years in the control group (p =
0.42). There were 35 females and 3 males in the mi-
graine group and 40 females and 4 males in the control
group (p = 0.84). The two groups were equivalent in
terms of ethnicity. There was no difference in the re-
fractive status between groups (p = 0.77). The mean
number of migraine attacks per month was 4.30 ± 2.50.
The mean length of migraine history was 3.72 ±
3.16.months.
Fig. 1 Topographic measurement of PPAA. This migraine patient has a few gray cells, but no black cells and no significant hemisphere asymmetry
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The OPA value was 2.78 ± 1.02 mmHg and 2.61 ±
0.81 mmHg in the migraine and the control group re-
spectively (p = 0.48). The correlation between OPA and
the mean RNFL thickness in the migraine and the con-
trol group is shown in Fig. 3. There was no correlation
between OPA and mean RNFL thickness (r = 0.19, p =
0.26), mean GCL thickness (r = 0.06, p = 0.56), macular
thickness (r = 0.23, p = 0.16), MD (r = 0.01, p = 0.95) and
PSD (r = -0.37, p = 0.12) in the migraine group.
The difference in PPAA between the two groups was
not statistically significant (p = 0.83). The PPAA of a mi-
graine patient is shown in Fig. 2. Table 1 shows the
macular thickness measurements and Table 2 shows the
GCL thickness measurements in both groups. RNFL
Fig. 2 Topographic measurement of GCL thickness of a patient in the study
Fig. 3 Correlation between OPA and mean RNFL thickness in the (a) migraine and (b) control groups
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thickness was significantly lower in the temporal and the
nasal superior sectors in migraine group as shown in
Table 3. Illness duration or frequency did not show a
correlation with OPA, RNFL thickness, macular thick-
ness, GCL thickness, MD or PSD.
In the visual field testing; the MD was -2.90 ± 1.81 dB
and -2.32 ± 1.86 dB, the PSD was 2.01 ± 0.55 dB and
1.90 ± 0.73 dB in the migraine and the control groups,
respectively. The difference between the two groups was
not statistically significant (p = 0.24 for MD and p = 0.51
for PSD). In the migraine group there was no correlation
between MD and RNFL in any sector but there was
a negative correlation between PSD and mean RNFL
(p = 0.01, r = -0.54) and in some sectors including
temporal superior (p = 0.03, r = -0.48) nasal superior
(p = 0.04, r = -0.45), nasal inferior (p = 0.02, r = -0.52).
Fig. 4 shows visual field defects and sectorial RNFL
thinning in a migraine patient.
Discussion
Our findings suggest that the choroidal perfusion
assessed by OPA, is not significantly different between
the migraine patients and the controls. Similarly, PPAA
is not significantly different between the groups. However,
there is significant sectoral RNFL thinning which correlates
with PSD –an indicator of localized visual field defects- but
not with OPA in migraine patients without aura.
Recent studies have reported choroidal and retinal in-
volvement in migraine patients [4, 5, 15]. Using colored
doppler ultrasonography, reduction of blood flow has
been shown in both the central retinal artery and posterior
ciliary artery in migraine patients without aura compared
to healty subjects [16]. Decrease in choroidal blood flow
by stimulation of choroidal sympathetic supply [17, 18],
amaurosis fugax in young migraneurs [19] and pigmentary
changes on fundus examination following attacks [20]
were suggested as signs of affected choroidal circulation in
migraine. OPA reflects pulsatile variations in IOP which
corresponds to the blood volume (mostly from the chor-
oidal bed) pumped into the eye during each cardiac cycle
[10, 11]. Therefore, OPA was suggested as an indirect in-
dicator of choroidal blood flow and has been investigated
in several disorders with vascular origin [10, 21, 22]. De-
creased OPA values were reported in patients with carotid
artery stenosis, uveitis, normal tension glaucoma and pri-
mary open angle glaucoma [10, 23]. We assessed the chor-
oidal blood flow by measuring OPA and could not find a
significant difference in OPA between the migraine group
and controls. The result of this study shows that there is a
possibility that the pulsative choroidal blood flow is not
affected in patients without aura. This outcome does not
rule out the involvement of choroidal perfusion but rather
shows that the pulsative choroidal blood flow is not per-
manently compromised in this subgroup.
If migraine might affect the peripapillary RNFL, it
might also affect the GCL. The GCL is thickest at macula
and the RNFL is thickest at peripapillary region [24].
Although glaucoma damages both GCL and RNFL, the
peripapillary RNFL thickness has been shown to be more
sensitive in the detection of glaucoma [25]. In recent years
measurements of inner macular layers consisting of GCL,
RNFL and the inner plexifom layer and macular asym-
metry has been reported as an early predicting sign of
glaucoma damage [12, 24]. Heidelberg SD-OCT has a new
macular map consisting of 64 cells which may give a
chance of a particular macular hemisphere analysis
[12, 26]. PPAA may show the early damage of the
nerve fiber layer, which usually starts in one hemi-
sphere, by comparing the cells of two hemispheres.
But in the progressive retinal fiber layer loss, an
asymmetry is not usually present as advanced fiber
loss includes both hemispheres [12]. Performing this
test in migraneurs may not only provide data about
macular nerve damage, but also may help detect an
early onset of normal tension glaucoma in these patients.
There was no significant difference between the two
groups with cell to cell comparison. We also compared
Table 1 Macular thickness measurements in migraine and
control group
Macular thickness (μm) Migraine
(n = 38)
Control (n = 44) p value
Macular thickness 296.80 ± 12.47 299.02 ± 12.86 0.46
Superior hemifield thickness 296.83 ± 12.92 297.73 ± 13.63 0.77
Inferior hemifield thickness 297.58 ± 12.55 299.78 ± 12.90 0.47
Table 2 GCL thickness measurements in the migraine and
control groups
GCL thickness (μm) Migraine
(n = 38)
Control (n = 44) p value
Mean GCL thickness 42.84 ± 4.14 44.53 ± 3.81 0.07
Central sector GCL thickness 12.79 ± 3.42 13.00 ± 3.04 0.78
GCL Ganglion cell layer
Table 3 RNFL thickness measurements in the migraine and
control groups
RNFL Thickness (μm) Migraine (n = 38) Control (n = 44) p value
Mean RNFL 102.39 ± 8.91 105.63 ± 10.64 0.15
Temporal inferior 151.64 ± 17.95 157.89 ± 20.88 0.16
Temporal 71.47 ± 10.29 77.93 ± 11.34 0.01
Temporal superior 142.38 ± 13.50 143.27 ± 22.10 0.83
Nasal superior 103.94 ± 13.67 112.25 ± 22.02 0.04
Nasal 80.97 ± 13.73 76.93 ± 12.16 0.17
Nasal inferior 119.08 ± 19.68 119.48 ± 22.79 0.93
RNFL retinal nerve fiber layer
The bold p values were statically significant
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GCL and macular thickness in the two groups. Both GCL
and macular thickness measurements were thinner in
migraine patients but the difference was not statistically
significant. Reduction in macular thickness with accom-
panying peripapillary RNFL thinning was documented in
a migraine patient [27]. Ekinci et all reported decreased
GCL thickness measurements in migraine patients and
thinning in GCL was significant in migraine patients with
aura [15]. Our results may reflect that nerve damage is
not significant in the macular area in migraine patients
without aura.
RNFL thickness was significantly lower in the temporal
and nasal superior sectors. Inner retinal layers including
RNFL and GCL are supplied by retinal vessels and outer
retinal layers are supplied by choroidal vessels [28]. In
contrast to choroidal vessels, retinal vessels have no
autonomic innervations [29]. During an acute attack, the
neural events result in dilation of blood vessels that
cause nerve activation and vasoactive peptides being re-
leased into the extracerebral circulation. The vasoactive
substances initiate a neurogenic inflammation and these
neurovascular events are assumed to be the cause of
pain [1]. These vasoactive substances may also reduce
the ocular blood flow and adequate oxygen may not be
provided to the retinal neural cells, which may result in
cell deterioration. Ekinci et al showed that RNFL thick-
ness was thinner in migraine patients with aura,
compared with patients without aura and healthy con-
trols [15]. Gipponi and Martinez reported a reduction in
RNFL thickness in migraine patients with and without
aura [4, 5]. In this study we reported decreased RNFL
thickness in patients without aura which may suggest
that the neurovascular pathway underlying the migraine
may play a role in reducing RNFL thickness independent
of aura. Previous studies have reported segmental thinning
of the temporal and superior RNFL which is consistent
with our results [4, 5]. Finding RNFL thinning in similar
sectors may be accidental or may be specific for migraine
disease. There was no correlation between RNFL thinning
and illness duration or frequency, however to exclude
patients with anti-migraine drug use, we had to include
patients who had newly diagnosed migraine or had short
illness duration. Therefore, a long term follow-up is
needed to observe the course of thinning.
In the visual field testing, both MD and PSD were
worse in the migraine group, but the difference was not
statistically significant and no correlation was found
between MD, PSD and illness duration or frequency.
Unexpectedly, MD was -2.32 ± 1.86 dB in controls,
which might be a result of the practice and learning effect.
Migraine patients had localized superior and inferior
hemifield visual field losses (25 %), most of which corre-
lated with the thinning of the corresponding RNFL quad-
rants. There was no correlation between MD and RNFL
Fig. 4 Visual field defects and sectorial RNFL thinning of a migraine patient in the study
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in any sector, but there was a negative correlation between
PSD and the mean RNFL, temporal superior, nasal
superior and nasal inferior sectors. General reduction
of sensitivity was present in 10 % of migraine pa-
tients. Different forms of visual field defects, most of
which were present in the midperipheral field have
been reported in migraneurs, reflecting a precortical
region [30, 31]. Cortical visual field defects are not
common in migraine patients [32]. Because of the re-
lationship between normal tension glaucoma and mi-
graine, migraine patients who have RNFL thinning
and visual field defects, even though they have no
glaucomatous cupping, should be carefully monitored,
in terms of glaucoma.
Our study has several limitations. Firstly; OPA measure-
ments could not be obtained during migraine attacks
because most of the patients were not able to show up
during their attacks. Secondly; choroidal thickness with
enhanced deep imaging OCT should have been measured
and the results should have been compared between
groups. Lastly; It would be better to evaluate the choroidal
doppler ultrasound and correlate it with OPA findings.
Conclusions
In migraine patients without aura, the pulsative choroidal
blood flow is not affected, at least between attacks. There
is significant sectorial RNFL thinning which correlates with
localized visual field defects. This finding may indicate an
axonal insult and the necessity of monitoring RNFL and
visual field testing in migraine patients without aura.
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